FDA Advisory Committee Calendar

Tier 1: Established: peer-reviewed research or government health authority
Publisher: U.S. Food and Drug Administration · Published: July 24, 2026 · Accessed: August 11, 2026

Visit the source ↗

Claims this source supports

• FDA advisory committees are independent panels that advise the agency; their votes inform regulatory decisions but are not drug approvals.
• In July 2026, an FDA advisory committee voted on whether certain peptides should be permitted for compounding under the agency's bulk drug substances process.
• A compounding decision means a substance may be eligible for compounding under specific conditions; it does not establish that a drug is safe and effective for general use.
• No gray-market peptide (BPC-157, TB-500, MOTS-c, Epitalon) is FDA-approved for the anti-aging, healing, or energy claims made about it.